Facebook Twitter LinkedIn Google Plus RSS

Pacira Pharmaceuticals announces proposed public offering of stock

By ,

Parsippany-based Pacira Pharmaceuticals Inc. announced Tuesday that it is offering $100 million of its common stock in a proposed public offering.

According to the release, Pacira plans to grant underwriters 30 days to purchase up to $15 million of additional shares.

Jeffries LLC, Barclays Capital Inc. and BofA Merrill Lynch are acting as the joint bookrunning managers and underwriters for the offering.


Green developer Jonathan F. P. Rose preaches sustainability with South Orange site

NJBIZ names the 2014 General Counsel of the Year finalists

Small business owners: Stronger NJ grant process not working

More From This Industry

Emily Bader

Emily Bader

Emily Bader is the Web Editor and Social Media Coordinator at NJBIZ. She is a Brielle, N.J. native and a Rutgers University alum. You can contact her at emilyb@njbiz.com.

Leave a Comment


Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy